Trial intelligence / Profile preview

Incidence of cutaneous complications in advanced solid cancer patients treated with EGFR inhibitors

TCTR20170727001Not yet recruiting

Sponsor
Quality Improvement Fund, King Chulalongkorn Memorial Hospital
Start
Jul 2017
Countries
1
01

Overview

Single-arm trial in Non-hematologic malignancy, sponsored by Quality Improvement Fund, King Chulalongkorn Memorial Hospital. Primary endpoint: Incidence of cutaneous complications. Planned start Jul 2017; status: not yet recruiting.

02

Conditions

Non-hematologic malignancy

Beyond the preview

Go deeper on TCTR20170727001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170727001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call